Cytosorbents Corp 4
4 · Cytosorbents Corp · Filed Sep 22, 2014
Insider Transaction Report
Form 4
Gunton James T.
Director
Transactions
- Sale
Common Stock
2014-09-15$0.24/sh−17,600$4,224→ 1,384,551 total(indirect: By Partnership)
Footnotes (2)
- [F1]Sale conducted pursuant to a 10b5-1 trading plan effective as of September 9, 2014 and adopted by NJTC Investment Find, LP, of which the Reporting Person is a partner, in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]These securities are held directly by NJTC Investment Fund, LP, of which the Reporting Person is a partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, or any other purpose.